Branched-chain Amino Acids Supplementation and Resistance Exercise-induced Muscle Damage and Inflammation

Sponsor
University of Sao Paulo (Other)
Overall Status
Suspended
CT.gov ID
NCT01305018
Collaborator
(none)
30
1
3
12
2.5

Study Details

Study Description

Brief Summary

This study aims to evaluate the effects of branched-chain amino acids (BCAA) supplementation on resistance exercise-induced muscle damage and inflammation.

Condition or Disease Intervention/Treatment Phase
  • Dietary Supplement: BCAA
  • Dietary Supplement: Leucine
  • Dietary Supplement: Placebo
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
30 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Investigator)
Primary Purpose:
Treatment
Official Title:
Effects of Leucine and Branched-chain Amino Acids (BCAA) Supplementation on Resistance Exercise-induced Muscle Damage and Inflammation: a Randomized, Double-blind, and Placebo-controlled Study
Study Start Date :
Aug 1, 2011
Anticipated Primary Completion Date :
Jan 1, 2012
Anticipated Study Completion Date :
Aug 1, 2012

Arms and Interventions

Arm Intervention/Treatment
Experimental: Exercise and BCAA

Dietary Supplement: BCAA
7 g of leucine + 3,5 g of isoleucine + 3,5 g of valine per day during 9 days

Experimental: Exercise and Leucine

Dietary Supplement: Leucine
7 g of leucine + 7 g of alanine per day during 9 days

Placebo Comparator: Exercise and Placebo

Dietary Supplement: Placebo
14 g of alanine per day during 9 days

Outcome Measures

Primary Outcome Measures

  1. Muscle maximal strength [4 days]

  2. Muscle edema [4 days]

  3. Muscle soreness [4 days]

Secondary Outcome Measures

  1. Muscle inflammation [4 days]

    Immunohistochemistry, protein expression.

  2. Muscle damage [4 days]

    Serum creatine kinase

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 30 Years
Sexes Eligible for Study:
Male
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Sedentary;

  • No muscle disorders;

  • Must be able to swallow tablets

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of São Paulo - School of Physical Education and Sports São Paulo Brazil 05508-030

Sponsors and Collaborators

  • University of Sao Paulo

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT01305018
Other Study ID Numbers:
  • 071287
First Posted:
Feb 28, 2011
Last Update Posted:
May 5, 2011
Last Verified:
Apr 1, 2011

Study Results

No Results Posted as of May 5, 2011